Optimizing radiomics for prostate cancer diagnosis: feature selection strategies, machine learning classifiers, and MRI sequences
Eugenia Mylona(University of Ioannina), Jurgita Ušinskienė(National Cancer Institute), Fırat Atak(Hacettepe University), Muşturay Karçaaltıncaba(Institut d'Investigació Biomèdica de Girona), Stelios Sfakianakis(Foundation for Research and Technology Hellas), Charalampos Kalantzopoulos(University of Ioannina), Kostas Marias(Hellenic Mediterranean University), Anindo Saha(Radboud University Nijmegen), Jasper J. Twilt(Radboud University Nijmegen), Varvara Kalokyri(Foundation for Research and Technology Hellas), Silvia Navarro(Instituto de Investigación Sanitaria La Fe), Jurgen J. Fütterer(Radboud University Nijmegen), Eleftherios Trivizakis(Foundation for Research and Technology Hellas), Emanuele Neri(University of Pisa), Gloria Ribas(Instituto de Investigación Sanitaria La Fe), Dimitrios I. Fotiadis(University of Ioannina), Deniz Akata(Hacettepe University), Vincenzo Mendola(University of Pisa), Nikolaos S. Tachos(University of Ioannina), Nan Nan(Hacettepe University), Avtantil Dimitriadis(Champalimaud Foundation), Dimitrios I. Zaridis(National Technical University of Athens), Joan C. Vilanova(Institut d'Investigació Biomèdica de Girona), Daniele Regge(Candiolo Cancer Institute), Ana Sofia Castro Verde(Champalimaud Foundation), Giacomo Aringhieri(University of Pisa), Luis Martí‐Bonmatí(Hospital Universitari i Politècnic La Fe), Ana Carolina Rodrigues(Champalimaud Foundation), Henkjan Huisman(Radboud University Nijmegen), Lorenzo Tumminello(University of Pisa), José Guilherme de Almeida(Universidade do Porto), Grigorios Kalliatakis(Foundation for Research and Technology Hellas), Maarten de Rooij(Radboud University Nijmegen), Manolis Tsiknakis(Hellenic Mediterranean University), Nuno M. Rodrigues(Champalimaud Foundation), Leonor Cerdá-Alberich(Instituto de Investigación Sanitaria La Fe), Miguel Chambel(Champalimaud Foundation), Ali Devrim Karaosmanoğlu(Hacettepe University), Manuel Marfil(University of Pisa), Mustafa Özmen(Hacettepe University)
Cited by 37
Related Papers
Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial
|The Lancet Oncology|2016|1k
Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study
|The Lancet Oncology|2024|305
METhodological RadiomICs Score (METRICS): a quality scoring tool for radiomics research endorsed by EuSoMII
|Insights into Imaging|2024|286